Details
| Stereochemistry | MIXED |
| Molecular Formula | C14H18ClN |
| Molecular Weight | 235.752 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1NC(CC1C2=CC=C(Cl)C=C2)C3CC3
InChI
InChIKey=PZJBWSQQDMRZHY-UHFFFAOYSA-N
InChI=1S/C14H18ClN/c1-9-13(8-14(16-9)11-2-3-11)10-4-6-12(15)7-5-10/h4-7,9,11,13-14,16H,2-3,8H2,1H3
| Molecular Formula | C14H18ClN |
| Molecular Weight | 235.752 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/990622
8 mg/kg in mice and 4 mg/kg in rats for 12 days
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:19:10 GMT 2025
by
admin
on
Mon Mar 31 18:19:10 GMT 2025
|
| Record UNII |
S8K2JDR3NZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29728
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70866933
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | |||
|
4569
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | |||
|
3817
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | |||
|
100000082473
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | |||
|
SUB09809MIG
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | |||
|
C75116
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | |||
|
m891
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
S8K2JDR3NZ
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | |||
|
Picilorex
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | |||
|
62510-56-9
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105225
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY | |||
|
191657
Created by
admin on Mon Mar 31 18:19:10 GMT 2025 , Edited by admin on Mon Mar 31 18:19:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |